176 related articles for article (PubMed ID: 27326952)
1. A case of chronic myeloid leukaemia in blast transformation with leukemic ascites.
Mohd Ridzuan MS; Yap E; Wan Fariza WJ; Fadilah SA; Salwati S
Med J Malaysia; 2016 Apr; 71(2):85-7. PubMed ID: 27326952
[TBL] [Abstract][Full Text] [Related]
2. Bilineal Extramedullary Blast Crisis as an Initial Presentation of Chronic Myeloid Leukemia: A Case Report and Literature Review.
Gao X; Li J; Wang L; Lin J; Jin H; Xu Y; Wang N; Zhao Y; Liu D; Yu L; Wang Q
Am J Case Rep; 2016 Oct; 17():793-798. PubMed ID: 27784881
[TBL] [Abstract][Full Text] [Related]
3. Mixed phenotype (T/B/myeloid) extramedullary blast crisis as an initial presentation of chronic myelogenous leukemia.
Qing X; Qing A; Ji P; French SW; Mason H
Exp Mol Pathol; 2018 Apr; 104(2):130-133. PubMed ID: 29501750
[TBL] [Abstract][Full Text] [Related]
4. Biphenotypic extramedullary blast crisis as a presenting manifestation of Philadelphia chromosome-positive CML in a child.
Ganessan K; Goel R; Kumar K; Bakhshi S
Pediatr Hematol Oncol; 2007; 24(3):195-8. PubMed ID: 17454789
[TBL] [Abstract][Full Text] [Related]
5. A case of non-Hodgkin lymphoma in a patient with chronic myeloid leukemia.
Găman AM; Dobrea C; Rotaru I
Rom J Morphol Embryol; 2013; 54(4):1141-5. PubMed ID: 24399014
[TBL] [Abstract][Full Text] [Related]
6. Extramedullary blast crisis in chronic myeloid leukemia--a case report.
Tondon R; Singh PA; Misra V; Singh M; Mohan S
Indian J Pathol Microbiol; 2005 Apr; 48(2):253-4. PubMed ID: 16758687
[TBL] [Abstract][Full Text] [Related]
7. An unusual case of extramedullary blast crisis in chronic myelocytic leukaemia.
Feng CS
Am J Hematol; 1988 Oct; 29(2):117-9. PubMed ID: 3189299
[TBL] [Abstract][Full Text] [Related]
8. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
9. Case of CML lymphoid blast crisis presenting as bilateral breast masses.
Hossain A; Gupta K; Mener A; Tabbara I
BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27511749
[TBL] [Abstract][Full Text] [Related]
10. Spontaneous splenic rupture in atypical (Philadelphia chromosome negative) chronic myeloid leukaemia following blastic crisis.
Sachithanandan A; Gleadhill I; Alexander HD; Morris TC
Ir Med J; 2003 Jun; 96(6):181-2. PubMed ID: 12926761
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and survival outcomes in patients with chronic myeloid leukemia in blast phase in the tyrosine kinase inhibitor era: Cohort study of 477 patients.
Jain P; Kantarjian HM; Ghorab A; Sasaki K; Jabbour EJ; Nogueras Gonzalez G; Kanagal-Shamanna R; Issa GC; Garcia-Manero G; Kc D; Dellasala S; Pierce S; Konopleva M; Wierda WG; Verstovsek S; Daver NG; Kadia TM; Borthakur G; O'Brien S; Estrov Z; Ravandi F; Cortes JE
Cancer; 2017 Nov; 123(22):4391-4402. PubMed ID: 28743165
[TBL] [Abstract][Full Text] [Related]
12. Specific point mutations that activate v-abl are not found in Philadelphia-negative chronic myeloid leukaemia, Philadelphia-negative acute lymphoblastic leukaemia or blast transformation of chronic myeloid leukaemia.
Melo JV; Goldman JM
Leukemia; 1992 Aug; 6(8):786-90. PubMed ID: 1353550
[TBL] [Abstract][Full Text] [Related]
13. Relapse into blast crisis following bone marrow transplantation for chronic phase chronic myeloid leukaemia: a report of five cases.
Cullis JO; Marks DI; Schwarer AP; Barrett AJ; Hows JM; Swirsky DM; Goldman JM
Br J Haematol; 1992 Jul; 81(3):378-82. PubMed ID: 1390210
[TBL] [Abstract][Full Text] [Related]
14. Immunophenotypic characteristics of blast crisis of chronic myeloid leukaemia: correlations with clinico-biological features and survival.
Urbano-Ispizua A; Cervantes F; Matutes E; Villamor N; Pujades A; Sierra J; Feliu E; Vives-Corrons JL; Montserrat E; Rozman C
Leukemia; 1993 Sep; 7(9):1349-54. PubMed ID: 8371586
[TBL] [Abstract][Full Text] [Related]
15. Amplification of BCR-ABL and t(3;21) in a patient with blast crisis of chronic myelogenous leukemia.
Phan CL; Megat Baharuddin PJ; Chin LP; Zakaria Z; Yegappan S; Sathar J; Tan SM; Purushothaman V; Chang KM
Cancer Genet Cytogenet; 2008 Jan; 180(1):60-4. PubMed ID: 18068536
[TBL] [Abstract][Full Text] [Related]
16. Chronic myeloid leukemia stem cells.
Jamieson CH
Hematology Am Soc Hematol Educ Program; 2008; ():436-42. PubMed ID: 19074122
[TBL] [Abstract][Full Text] [Related]
17. Coexistence of translocation(1,19) and the Philadelphia chromosome in a child's first presentation of chronic myeloid leukemia in blast crisis treated with dasatinib.
Eckardt MA; Chang VY; Rao NP; Federman N
Pediatr Hematol Oncol; 2011 Nov; 28(8):669-75. PubMed ID: 22023462
[TBL] [Abstract][Full Text] [Related]
18. Unusual clinical course of chronic myelogenous leukemia. A case report.
Kusumakumari P; Kumar SR; Pillai GR
Am J Clin Oncol; 1994 Feb; 17(1):19-21. PubMed ID: 8311002
[TBL] [Abstract][Full Text] [Related]
19. U.S. Food and Drug Administration Drug Approval Summary: conversion of imatinib mesylate (STI571; Gleevec) tablets from accelerated approval to full approval.
Cohen MH; Johnson JR; Pazdur R
Clin Cancer Res; 2005 Jan; 11(1):12-9. PubMed ID: 15671523
[TBL] [Abstract][Full Text] [Related]
20. BCR-ABL positive essential thrombocythaemia: a variant of chronic myelogerous leukaemia or a distinct clinical entity: a special case report.
Fadilah SA; Cheong SK
Singapore Med J; 2000 Dec; 41(12):595-8. PubMed ID: 11296785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
